US Patent Issued to Genzyme on Aug. 25 for "Anti-complement factor Bb antibodies and uses thereof" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,910, issued on Aug. 25, was assigned to Genzyme Corp. (Framingham, Mass.).

"Anti-complement factor Bb antibodies and uses thereof" was invented by Sandip Panicker (South San Francisco, Calif.), Graham Parry (Cambridge, Mass.), Karen Sue Christopherson (San Mateo, Calif.) and Tony SangYoung Byun (Brisbane, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides anti-complement factor Bb antibodies, and compositions comprising the antibodies. The anti-Bb antibodies are useful for treating complement-me-diated disorders. The present disclosure provides methods of treating complement-mediated disorders."

The patent was fil...